156 related articles for article (PubMed ID: 32621636)
21. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M
Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081
[TBL] [Abstract][Full Text] [Related]
22. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
23. T-cell lymphoblastic lymphoma presenting with pleural effusion: A case report.
He XL; Yu F; Guo T; Xiang F; Tao XN; Zhang JC; Zhou Q
Respir Med Case Rep; 2014; 12():55-8. PubMed ID: 26029543
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions.
Berner HS; Davidson B; Berner A; Risberg B; Nesland JM
Virchows Arch; 2000 Apr; 436(4):330-5. PubMed ID: 10834535
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
[TBL] [Abstract][Full Text] [Related]
26. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center.
Patel T; Patel P; Mehta S; Shah M; Jetly D; Khanna N
Diagn Cytopathol; 2019 Aug; 47(8):776-782. PubMed ID: 31091023
[TBL] [Abstract][Full Text] [Related]
27. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S
Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505
[TBL] [Abstract][Full Text] [Related]
30. The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology.
Nagel H; Hemmerlein B; Ruschenburg I; Hüppe K; Droese M
Pathol Res Pract; 1998; 194(11):759-64. PubMed ID: 9842634
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of MOC-31, HBME-1 and MOC-31 mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions.
Sun Y; Wu GP; Fang CQ; Liu SL
Acta Cytol; 2009; 53(6):619-24. PubMed ID: 20014549
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
[TBL] [Abstract][Full Text] [Related]
33. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
Chen CJ; Chang SC; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
[TBL] [Abstract][Full Text] [Related]
34. Emperipolesis in a case of B-cell lymphoma: a rare phenomenon outside of Rosai-Dorfman disease.
Lopes LF; Bacchi MM; Coelho KI; Filho AA; Bacchi CE
Ann Diagn Pathol; 2003 Oct; 7(5):310-3. PubMed ID: 14571435
[TBL] [Abstract][Full Text] [Related]
35. Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
Rehnberg J; Zendehrokh N; Dejmek A
Anal Quant Cytol Histol; 2007 Aug; 29(4):217-20. PubMed ID: 17879629
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
37. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
[TBL] [Abstract][Full Text] [Related]
38. Cytologic and Immunophenotypic Features of Malignant Cells in Pediatric Body Fluids.
Ahmed AA; Andraws N; Almutairi AM; Saied HM; Elbagir-Mohamed AM
Acta Cytol; 2015; 59(4):332-8. PubMed ID: 26422236
[TBL] [Abstract][Full Text] [Related]
39. Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions.
Cozzi I; Oprescu FA; Rullo E; Ascoli V
Diagn Cytopathol; 2018 Jan; 46(1):9-14. PubMed ID: 28994508
[TBL] [Abstract][Full Text] [Related]
40. Converting fluid-based cytologic specimens to histologic specimens for immunohistochemistry.
Wallace KA; Goldschmidt MH; Patel RT
Vet Clin Pathol; 2015 Jun; 44(2):303-9. PubMed ID: 25639814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
